CAAS Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Hold |
0
| – | – | – | 210 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 173 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 152 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 149 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 198 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 239 |
|
2023
Q3 | – | Sell |
-1,800
| Closed | -$170K | – | 301 |
|
2023
Q2 | $170K | Buy |
+1,800
| New | +$170K | 0.01% | 133 |
|
2023
Q1 | – | Sell |
-7,000
| Closed | -$522K | – | 383 |
|
2022
Q4 | $522K | Buy |
+7,000
| New | +$522K | 0.03% | 147 |
|